◆ 会议时间:2026年4月23-26日
◆ 会议地点:美国 西棕榈滩
◆ 会议简介:
2026年国际骨关节炎研究学会(OARSI)世界大会-世界骨关节炎大会将于2026年4月23-26日在美国佛罗里达州西棕榈滩举行,预计有来自世界各地的1000余名代表参会。
国际骨关节炎研究学会(OARSI)成立于1990年,是全球唯一的专注于骨关节炎研究的国际权威医学组织,其宗旨是鼓励及促进与骨关节炎相关的基础与临床研究,分享最新的研究成果,传播骨关节炎研究进展,带动全世界骨关节炎基础研究、疾病预防及诊断治疗的发展。OARSI在全球拥有超过1900名成员,包括医生、研究人员和对骨骼、滑膜和软骨疾病研究感兴趣的其他卫生行业人士。
国际骨关节炎研究学会于每年4月下旬在欧洲与北美轮流举行年会(OARSI世界大会),每届会议都吸引了世界各地的骨关节炎研究学者参加,包括基础研究学者、临床研究学者、放射科医生、风湿科医生、骨科医生、初级保健医生及康复医生等,分享骨关节炎领域宣的最新研究进展,促进骨关节炎学术交流。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
2026 OARSI World Congress on Osteoarthritis
Osteoarthritis Research Society International (OARSI) World Congress
Date:
April 23 -26, 2026
Venue:
Palm Beach County Convention Center
West Palm Beach, FL
United States
摘要征文投稿:
Abstract Submission
Original Abstract Submission
- Mid-September 2025 – Online submission site opens.
- November 19, 2025 – Online submission deadline.
- January 2026 – Abstract status notifications sent.
Late Breaking Abstract Submission
- January 2026 – Online submission site opens.
- February 11, 2026 – Online submission deadline.
- Mid-February 2026 – Late breaking abstract status notifications sent.
点此提交摘要>>>Submit Abstract>>>
Abstract Preparation Checklist
- Abstract prepared and formatted as outlined in the SUBMISSION PROCEDURES section.Abstracts that are not properly prepared and formatted are subject to automatic rejection.
- Original and late breaking abstracts (subject to acceptance) will be presented and placed (oral podium presentation or poster presentation) by the OARSI Program Planning Committee.
- License is granted to the OARSI to publish the abstract (subject to acceptance) online.
- Designated presenting author registered for the OARSI 2026 World Congress and has paid the registration fee. All abstract submitters including presenting authors are expected to pay their own travel expenses and Congress registration fee(s).
Submission Guidelines
Abstract Categories
Abstract categories are used by the OARSI Program Planning Committee to classify abstracts for review and organization of the final abstract program. You must submit your abstract to one of the following categories below:
- Advanced Bioinformatics in OA and Clinic
- Biomarkers
- Biomechanics & Gait
- Clinical Digital Innovations, Implementation Research and Health Services
- Early Stage OA and Prevention
- Epidemiology, Clinical Aspects & Outcomes
- Functional Genomics in OA
- Imaging Phenotypes and Outcomes
- Imaging: Methods and Innovations
- Immunology in OA
- Innovative Therapeutics
- Joint Related Tissues
- Mechanistic Studies of OA
- Multi-Omics Characterization of OA
- OA in the Spine and Other Joints
- Pain: From Mechanistic to Clinical Aspects
- Pharmacological Innovations
- Pre-clinical and Developmental Models
- Rehabilitation Medicine & Non-Pharmacological Innovations
- Surgical Innovations and Interventional Procedures
- Systemic Factors & Comorbidities
Abstract Results
- Please do not include statements such as “the results will be discussed” or “data will be presented and discussed” within your conclusion, as these are NOT acceptable.
Fees
- The Cost per abstract submission is $35 USD.
- The submission fee is required at the time of submission and is accepted by online credit card payment only.
- A submission is not complete without payment.
- Payment will be displayed as “OARSI” on credit card statements.
Character Limit
- The maximum character limit is 5,000.
- The character limit includes title, abstract body, spaces, tables, images and image tables.
- An Image File can have a maximum file size of UP TO 50 megabytes (MB) which will reduce the character count by a maximum of 560 characters.
- Each abstract can have a maximum of 4 Image files.
- Each row of a Table will reduce character size by 50 characters.
- Each abstract can have a maximum of 2 separate tables.
Online Submission
- Abstracts must be submitted online through the OARSI abstract submission portal managed by ScholarOne.
- No paper submissions will be accepted.
View / Edit / Withdraw Your Abstract
- You may view, edit, or withdraw your abstract submission(s) by logging into the OARSI online abstract portal.
- Abstract submissions may be edited or withdrawn until November 19, 2025.
Presentation Status Notification
- Acknowledgement of submission will be emailed to the presenting author as the primary contact.
- The presenting author will be notified of the original abstract status in January 2026.
- The presenting author will be notified of the late breaking abstract status in February 2026.
Presentation Format
- Accepted original and late breaking abstracts are presented in plenary, oral podium or poster presentation format.
OARSI World Congress Registration
- All oral and poster abstract presenting authors must register for the OARSI World Congress and pay the registration fee.
Submission Procedures
LEARN HOW TO PREPARE AND SUBMIT YOUR ABSTRACT
Audience
The OARSI World Congress on Osteoarthritis is designed for academia and industry, including basic scientists, clinical investigators, radiologists, rheumatologists, orthopedic surgeons, physicians in physical medicine and rehabilitation, allied health professionals, and policy makers.
The Congress attracts over 1,000 attendees from more than 40 countries to learn of the latest in research advancements, innovations, clinical trials, and new product introductions.
Format & Layout
- The OARSI World Congress is presented in English and therefore abstract submissions are to be written in English.
- Each abstract submission must confirm to the format & layout below.
Title
- The abstract title should be brief, in CAPITAL LETTERS, and should give a clear indication of the exact nature of the research and refer to the actual content of the abstract.
- Do not use abbreviations in the title.
Abstract Body Layout
Please organize the abstract body as follows:
- Purpose (the aim of the study)
- Methods
- Results
- Conclusions (Statements such as "the results will be discussed," or "data will be presented and discussed" are not acceptable.)
- DO NOT include titles, authors, or references in your abstract body.
- DO NOT include Images and Graphics in the abstract body as they can be uploaded separately.
Author Information
- There is no limit to the number of abstracts an author may submit.
- When submitting your abstract, you will need to enter each abstract author's name, email, and institution.
- Each abstract author will receive a notification from the submission platform alerting them they have been listed as an abstract co-author.
- If an abstract is accepted, the presenter must be one of the co-authors listed.
- Communications will only be sent to the designated presenting author.
- Please indicate the presenting author by selecting the button next to the author's name during submission.
- The presenting author is responsible for delivering the in person oral or poster presentation at Congress.
- All abstract submitters including presenting authors are expected to pay their own travel expenses and Congress registration fee(s).
- If the abstract author is not already in the submission database, you will need to create an account with the following information and they will receive a notification from the submission platform alerting them an account has been created:
- Name
- Email
- Institution
- City, State/Provence, Country
- *IMPORTANT*: Please make sure the above information is entered correctly before creating a co-author account. Once created, the information can only be edited by the co-author or the OARSI Staff.
- For full instructions on how to submit authors, please click HERE.
Dear Colleagues and Friends,
With great pleasure we welcome you to the 2026 Osteoarthritis Research Society International (OARSI) World Congress entitled “Waves of Innovation and Scientific Collaboration” on April 23-26, 2026 at, Palm Beach County Convention Center, Florida, USA. The annual OARSI Congress is the pre-eminent global forum for all those interested in cutting-edge osteoarthritis (OA) research from academia to the clinic and industry worldwide.
The theme of this year “Waves of Innovation and Scientific Collaboration” highlights the dedication of the OARSI to advancing the science and treatment of osteoarthritis through innovation, collaboration, and rigorous, reproducible research. By fostering open dialogue and bringing together diverse disciplines, we aim to spark idea’s and cross-disciplinary collaboration. We envision the OARSI World Conference as a catalyst to start new waves of innovation, discovery, and collaboration.
The OARSI is a platform to meet the diversity of osteoarthritis research: basic and clinical research scientists, rheumatologists, orthopaedic surgeons, radiologists, physiatrists, physical therapists, bioengineers, pain specialists and other healthcare professionals, regulators, and policymakers. As such it is the place to be for scientific collaboration, not only within scientific disciplines but also cross-disciplinary, from academia, clinicians, and industry.
This diversity is reflected in the program, where we bring together the latest innovations from a wide range of disciplines within the osteoarthritis research, from genetics and genomics, molecular biology, biomechanics, imaging, to clinical interventions, and data science. We bring you the cutting-edge discoveries and aim to broaden and deepen your view of osteoarthritis research to foster new questions, unexpected connections, and meaningful advances.
Please join us for this exciting opportunity to connect to OARSI’s global network of health care professionals and scientists and industry, with common goals of preventing, managing, and curing the disease, improving the quality of lives of over 600 million osteoarthritis patients worldwide!
We wish to thank all the OARSI staff, OARSI committees and volunteers, though collaboration and diversity we have been able to present an exciting and stimulating program for OARSI 2026.
We look forward to meeting you in person and fostering research connections during OARSI 2026 in the Palm Beach County Convention Center, Florida, USA.
With warm regards,
Martin Englund, MD, PhD
OARSI President
Cindy G. Boer, PhD
Congress Chair
Jessica Bertrand, PhD
Abstract Chair
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|